- Lobbying
- Lobbying by OSI Pharmaceuticals, Inc.
Lobbying Relationship
Bills mentioned
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
H.R.4872: Health Care and Education Reconciliation Act of 2010
Sponsor: John M. Spratt Jr. (D-S.C.)
S.1796: America's Healthy Future Act of 2009
Sponsor: Max Baucus (D-Mont.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Edward Baxter | Chief Counsel and Staff Director, Senate Judiciary Committee's Subcommittee on Patents, Copyrights and Trademarks: 1987 to 1990 |
Dennis DeConcini | U.S. Senator; 1977 to 1995 |
James Rock | Staff Asst, US House Committee on Budget - 1985 to 2000 |
Thaddeus Strom | Chief Counsel, Sen. Strom Thurmond: 1987 to 1988 Gen. Coun./Staff Dir. Sen Cmte on the Judiciary: 1988-1991 Chief Coun/Staff Dir Sen Cmte on the Judiciary: 1991-1993 Chief Counsel/Staff Director, Sen. Cmte. on Antitrust, Business Rights and Competition: 1994 to 1997 |
Steve Symms | U.S. Senator, 1981 to 1993 |
Romano Romani | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate